KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Liabilities and Shareholders Equity: 2017-2024

Historic Liabilities and Shareholders Equity for Elanco Animal Health (ELAN) over the last 8 years, with Dec 2024 value amounting to $12.6 billion.

  • Elanco Animal Health's Liabilities and Shareholders Equity rose 2.02% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 billion, marking a year-over-year decrease of 4.65%. This contributed to the annual value of $12.6 billion for FY2024, which is 12.17% down from last year.
  • According to the latest figures from FY2024, Elanco Animal Health's Liabilities and Shareholders Equity is $12.6 billion, which was down 12.17% from $14.4 billion recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Liabilities and Shareholders Equity registered a high of $17.7 billion during FY2020, and its lowest value of $12.6 billion during FY2024.
  • Its 3-year average for Liabilities and Shareholders Equity is $14.2 billion, with a median of $14.4 billion in 2023.
  • Per our database at Business Quant, Elanco Animal Health's Liabilities and Shareholders Equity surged by 96.90% in 2020 and then declined by 12.17% in 2024.
  • Yearly analysis of 5 years shows Elanco Animal Health's Liabilities and Shareholders Equity stood at $17.7 billion in 2020, then dropped by 6.87% to $16.5 billion in 2021, then declined by 5.99% to $15.5 billion in 2022, then declined by 7.29% to $14.4 billion in 2023, then decreased by 12.17% to $12.6 billion in 2024.